Adjuvant! Online
• A version of Adjuvant! Online that will include HER2 status and the potential
benefit of trastuzumab is in development
• Information about the efficacy of different therapy options are derived from
Early Breast Cancer Trialists Collaborative Group (EBCTCG) meta-
analyses in order to provide estimates of reduction in risk at 10 years of
breast cancer related death or relapse for selected treatments
19-9-2017
The basic format of an early version of Adjuvant! was described by Ravdin
Ravdin, Siminoff, Davis, et al. JCO
2001;19(4):980-991




